# Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation

> **NCT02346630** · PHASE4 · WITHDRAWN · sponsor: **Ross D. Zafonte, MD**

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Placebo
- **DRUG:** Levodopa / Carbidopa
- **DEVICE:** Armeo

## Key facts

- **NCT ID:** NCT02346630
- **Lead sponsor:** Ross D. Zafonte, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We didn't receive the expected funding to support the study.
- **Last updated:** 2021-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346630, "Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02346630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*